Pallidal lead placement in dystonia: leads of non-responders are contained within an anatomical range defined by responders. Zittel S, Hidding U, Trumpfheller M, Baltzer VL, Gulberti A, Schaper M, Biermann M, Buhmann C, Engel AK, Gerloff C, Westphal M, Stadler …
Novel Deep Brain Stimulation Technologies for Parkinson’s Disease: More Expectations, More Frustrations? Soh D, Ten Brinke TR, Lozano AM, Fasano A. Mov Disord Clin Pract. 2019 Nov 14;7(1):113-114. SUMMARY: This letter is highly eloquent. In comparing patients who were on …
The Effect of Unilateral Subthalamic Nucleus Deep Brain Stimulation on Contralateral Subthalamic Nucleus Local Field Potentials. Hasegawa H, Fischer P, Tan H, Pogosyan A, Samuel M, Brown P, Ashkan K. Neuromodulation. 2020 Apr 12; 23(4): 509–514. SUMMARY: STN LFPs were …
Zanello M, Benabid AL, Devaux B, Pallud J. Neurosurgery. 2019 Jun 1;84(6):E443. SUMMARY: The first paper tries to show the role and impact of the famous hospital in Paris to Neurosurgery. It is beautifully illustrated and shows also the portrait …
SUMMARY: The authors describe Avicenna´s origin and some of his work, including on trepanation, hydrocephalus, vermis etc, insisting that he was Persian, born to Persia, with Persian roots, he spoke Persian (although his writings were in Arabic) and should be …
SUMMARY: The authors aimed to update on the state of DBS-related clinical human research by cataloging and summarizing clinical trials that have been completed or are currently ongoing in this field worldwide. They searched for clinical trials pertaining to DBS, …
SUMMARY: 10 patients received bilateral anterior capsulotomy (BAC) for depression. 6 patients were responders (≥50% improvement in BDI), 4 patients non-responders (< 50% improvement). Tractography revealed that in the responder group, there was less involvement of the DLPFC pathways than …
SUMMARY: The authors analysed outcome of 54 consecutive anterior capsulotomy (AC) up to 36 months after surgery, according to phenotype. They found that AC is generally effective in reducing symptoms of most subtypes of OCD. However, patients categorized into the …
SUMMARY: This is the famous Medtronic-sponsored European open labeled multicenter study on OCD DBS that took long long time to complete and even longer time to publish judging by the use of Kinetra stimulator in most of the patients. It …
SUMMARY: Here the authors examined participants enrolled in a previous (failed) clinical trial of Subcallosal cingulum (SCC) DBS for treatment-resistant depression. 28 patients receiving SCC DBS for 4–8 years showed that response and remission rates were maintained at >50% and …